Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | REGN | ARGX | ||
| Company | Alnylam Pharmaceuticals | Regeneron Pharmaceuticals | Argenx Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 472.67 | 732.45 | 926.47 | ||
| High | 477.06 | 735.00 | 928.34 | ||
| Low | 463.03 | 721.22 | 915.83 | ||
| Latest | 465.34 | 722.80 | 915.97 | ||
| Change | -7.95 | -0.87 | -5.83 | ||
| % Change | -1.68% | -0.12% | -0.63% | ||
| Volume | 983,900 | 1,067,100 | 164,400 | ||
| 20-Day Average Volume | 957,085 | 1,154,640 | 338,580 | ||
| Previous Close | 473.29 | 723.67 | 921.80 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 450.85 | 719.07 | 902.86 | ||
| 20-Day Raw Stochastic | 75.71% | 54.59% | 81.96% | ||
| 20-Day Relative Strength | 54.56 | 59.02 | 64.78 | ||
| Weighted Alpha | +84.99 | +6.59 | +61.76 | ||
| Today's Opinion | 80% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 80% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 56% Buy | 72% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.54% since 11/26/25 | -7.88% since 11/26/25 | -0.18% since 11/26/25 | ||
| Low | 444.43 on 11/28/25 | 720.07 on 12/03/25 | 886.24 on 12/01/25 | ||
| High | 479.79 on 12/03/25 | 788.98 on 11/28/25 | 934.62 on 12/03/25 | ||
| 1-Month | |||||
| %Chg | +9.89% since 11/04/25 | +15.10% since 11/04/25 | +10.16% since 11/04/25 | ||
| Low | 417.00 on 11/05/25 | 628.00 on 11/05/25 | 812.79 on 11/05/25 | ||
| High | 479.79 on 12/03/25 | 790.98 on 11/26/25 | 934.62 on 12/03/25 | ||
| 3-Month | |||||
| %Chg | +2.60% since 09/04/25 | +27.43% since 09/04/25 | +24.85% since 09/04/25 | ||
| Low | 417.00 on 11/05/25 | 541.00 on 10/13/25 | 698.92 on 09/25/25 | ||
| High | 495.55 on 10/20/25 | 790.98 on 11/26/25 | 934.62 on 12/03/25 | ||
| 6-Month | |||||
| %Chg | +52.42% since 06/04/25 | +49.05% since 06/04/25 | +59.71% since 06/04/25 | ||
| Low | 295.82 on 06/12/25 | 476.49 on 06/05/25 | 510.05 on 06/30/25 | ||
| High | 495.55 on 10/20/25 | 790.98 on 11/26/25 | 934.62 on 12/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 61,477,920 | 75,965,552 | 56,395,356 | ||
| Shares Outstanding, K | 132,114 | 105,099 | 61,569 | ||
| Annual Sales | 2,248,240,000 | 14,202,000,000 | 2,252,040,000 | ||
| Annual Net Income | -278,160,000 | 4,412,600,000 | 833,040,000 | ||
| Last Quarter Sales | 1,249,030,000 | 3,754,300,000 | 1,151,340,000 | ||
| Last Quarter Net Income | 251,080,000 | 1,460,000,000 | 344,260,000 | ||
| 60-Month Beta | 0.30 | 0.37 | 0.37 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.90 on 10/30/25 | 11.83 on 10/28/25 | 5.18 on 10/30/25 | ||
| Latest Earnings Date | 10/30/25 | 10/28/25 | 10/30/25 | ||
| Most Recent Dividend | N/A | 0.880 on 11/20/25 | N/A | ||
| Next Ex-Dividends Date | N/A | 11/20/25 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 2,057.78 | 19.73 | 70.47 | ||